Welcome to Medications.com
Oryx Pharmaceuticals announces launch of NAPRELAN(TM) - Canada NewsWire (press release)
NAPRELAN(TM) is approved in Canada for the management of signs and symptoms of rheumatoid arthritis and osteoarthritis and is available in strengths of 375 ...
Posted: Mon Jul 16 16:07:24 -0400 2007
Naprelan '375' RSS Feed
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
